Victory Capital Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-544
| Closed | -$26K | – | 2637 |
|
|
2020
Q1 | $26K | Buy |
+544
| New | +$26K | ﹤0.01% | 3003 |
|
|
2019
Q4 | – | Sell |
-174
| Closed | -$7K | – | 2740 |
|
|
2019
Q3 | $7K | Buy |
+174
| New | +$7K | ﹤0.01% | 3364 |
|
|
2019
Q2 | – | Sell |
-127
| Closed | -$7K | – | 1830 |
|
|
2019
Q1 | $7K | Hold |
127
| – | – | ﹤0.01% | 1768 |
|
|
2018
Q4 | $6K | Hold |
127
| – | – | ﹤0.01% | 1774 |
|
|
2018
Q3 | $11K | Buy |
127
+17
| +15% | +$1.47K | ﹤0.01% | 1780 |
|
|
2018
Q2 | $11K | Hold |
110
| – | – | ﹤0.01% | 1808 |
|
|
2018
Q1 | $9K | Hold |
110
| – | – | ﹤0.01% | 1809 |
|
|
2017
Q4 | $15K | Hold |
110
| – | – | ﹤0.01% | 1795 |
|
|
2017
Q3 | $18K | Hold |
110
| – | – | ﹤0.01% | 1780 |
|
|
2017
Q2 | $17K | Buy |
110
+2
| +2% | +$309 | ﹤0.01% | 1776 |
|
|
2017
Q1 | $17K | Buy |
108
+26
| +32% | +$4.09K | ﹤0.01% | 1779 |
|
|
2016
Q4 | $17K | Buy |
+82
| New | +$17K | ﹤0.01% | 1766 |
|